Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is an investigator-initiated, randomized controlled trial in adult KTRs (N=50) with stable allograft function to assess: 1) the reversibility of the expected acute changes in eGFR with sotagliflozin (donated by Lexicon); 2) proportion of patients completing the protocol according to different eGFR reporting strategies (using a predefined algorithm to manage the expected pharmacological effect of sotagliflozin on eGFR); 3) safety and tolerability of sotagliflozin.
Epistemonikos ID: 5d9f502993f2f4ad7f23c4ba665c4e6f090fa7a7
First added on: May 13, 2024